Publications

Refined By:
Author:  Momir Mikov

Results 1-9 of 9 (Search time: 0.002 seconds).

Issue DateTitleAuthor(s)
11-Jun-2018Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and ProbioticsMomir Mikov ; Maja Đanić ; Nebojša Pavlović ; Bojan Stanimirov ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami
21-Dec-2012Pleiotropic functions of bile acids mediated by the farnesoid X receptorStanimirov, Bojan ; Stankov, Karmen ; Mikov, Momir 
31-Jan-2018Pharmacological applications of bile acids and their derivatives in the treatment of metabolic syndromeMaja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Svetlana Goločorbin-Kon ; Hani Al-Salami; Karmen Stankov ; Momir Mikov 
41-Feb-2013Pharmacogenetic biomarkers as tools for pharmacoepidemiology of severe adverse drug reactionsStankov, Karmen ; Sabo, Ana ; Mikov, Momir 
51-Jan-2012The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel diseaseStojancevic M.; Stankov, Karmen ; Mikov, Momir 
61-Apr-2012Ethical and legal aspects of oncogenomicsStankov, Karmen ; Drašković, Dragan ; Mikov, Momir 
71-Jan-2019DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal ImpairmentMikov, Momir ; Pavlović, Nebojša ; Stanimirov, Bojan ; Đanić, Maja ; Goločorbin-Kon, Svetlana ; Stankov, Karmen ; Al-Salami H.
81-Jan-2014C-KIT signaling in cancer treatmentStankov, Karmen ; Popović, Živko; Mikov, Momir 
91-Feb-2015Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseasesStanimirov, Bojan ; Stankov, Karmen ; Mikov, Momir